Diabetes Pro

ADA American Diabetes Association

Advanced Search Help

Home

Professional Education

Journals

Professional Resources

Research Grants

Recognition Programs

Membership

Webcasts

72nd Scientific Sessions
June 8 - 12, 2012
Pennsylvania Convention Center, Philadelphia, PA

List of all the Sessions for this Meeting:

ADA Diabetes Care Symposium
ADA Education Recognition Program Symposium–Chronicle Diabetes–On the Road to Quantifying the Impact of Diabetes Education
Adipocyte Biology
Alpha Cells and Beta Cells–Molecular Determinants
An Update on Insulin Therapies
Applications of High-Throughput Sequencing
Back to the Future–Insulin Action and Intermediary Metabolism
Behavioral Diabetes Interventions–Results from the Latest Controlled Trials
Behavioral Interventions in Routine Clinical Care–What Works?
Beta Cell Death, Cytokine Toxicity, and Islet Antigenicity
Beta Cell Origins and Proliferation in Mice and Humans
Beta Cell Replacement Therapies for Severe Hypoglycemia and Hypoglycemia Unawareness
Beyond Insulin and A1C in the Management of Pediatric Type 1 and Type 2 Diabetes
Brown and Browning–Adipose Tissue and Insulin Action
Brown Fat in Humans
Can We Rein In the Costs of Diabetes with Better Diabetes Care?
Cancer Link with Insulin–Data from the U.S. and Northern Europe
Cell Plasticity in the Adult Pancreas
Changing the Course of Diabetic Retinopathy
China Medical Tribune Symposium–A Perspective on “Metabetes” from China
Clinical Aspects of Hypoglycemia in Diabetes–Consequences and Prevention
Clinical Islet Transplantation
Clinical Nutrition
Closed Loop Systems
Continuous Glucose Monitoring
Continuous Glucose Monitoring–Practical Aspects
Current Status of Acute Complications of Pediatric Diabetes
Cytosolic Coupling Factors
Death of an Islet
DGATs and Insulin Action
Diabetes and Atherosclerosis–New Insights from Animal Models
Diabetes and Macronutrient Composition-Striving to Achieve Metabolic Goals
Diabetes and Macrovascular Disease–From Biomarkers to Therapeutics (includes Edwin Bierman Award Lecture)
Diabetes Complications and Mortality–Risk Factors, Trends, and Sex/Race Disparities
Diabetes is Primary
Diabetes Prevention and Lifestyle Risk Factors
Diabetes to Diabetic Kidney Disease–Easing the Nutritional, Medical, and Behavioral Transition
Diabetic Dyslipidemia
Diabetic Dyslipidemia in the Statin-Treated Patient (Supported by an unrestricted educational grant from Merck)
Diabetic Foot Disease–What Contributes to Healing? (Includes Roger Pecoraro Award Lecture)
Diabetic Retinopathy–Pathogenesis and New Approaches to Treatment
Dietary Fatty Acids–Effects on Insulin Sensitivity, Inflammation, and Vascular Function
Discovery of Molecules for Beta Cell Genesis
Early Adipose Development
Epidemiological Perspectives on Women's Health Issues in Type 1 Diabetes
Epidemiology of Geriatric Conditions in the Elderly with Diabetes–An Emerging Public Health Burden
Epigenetic Control of Insulin Action
Exercise Tolerance in Diabetes
Expanding the Domains of Diabetes Education
Exploring Nutritional Strategies for Preventing Adverse Developmental Programming in the Offspring–Pathogenesis and Mechanisms
Frontiers of the Diagnosis and Treatment of Neural Dysfunction
Fusion
Genetics–Clinical Implications
Genotype-Phenotype Correlations
Glucagon and Glucagon-Like Peptides–Animals
Glucagon—Renaissance of an Old Hormone
Glucose Transport and Insulin Resistance
Glycemic Variability
Health Care Delivery Is Changing—Where Do Diabetes Educators Fit?
Hot Topics in Diabetes, Dyslipidemia, and Cardiovascular Disease (Supported by an unrestricted educational grant from Merck)
Hot Topics in Human Obesity
How and Who Best Supports Diabetes Self-Management?
How to Measure Success in the Treatment of Diabetic Neuropathy
Human Immunology and Diabetes
Human Islet Investigation to Advance Research in Diabetes Mellitus
Hypoglycemia and the Brain
Hypoxia and Insulin Resistance
Immunometabolism
Impact of Exercise in Type 1 and Type 2 Diabetes
Improving Health Care Delivery and Health Outcomes for Diabetes
Incretin Therapies
Incretin-Based Therapies (Supported by an unrestricted educational grant from Merck)
Inflammation and Insulin Resistance
Inflammation in Type 2 Diabetes and Results of the TINSAL-T2D Trial
Innovative Insights in Islet Ion Channels
Inpatient Management of Diabetic Foot Disorders
Insulin Action in Animals
Insulin Action via the Brain
Insulin Action–Metabolism
Insulin Analogs
Insulin Signal Transduction and Action
Intra-Islet Communication
Islet Growth and Development
Joint ADA/AACC Symposium–How Should HbA1C Be Reported–% DCCT Units or mmol/mol? (Supported by an unrestricted educational grant from Merck)
Joint ADA/ASN Symposium–Structure Meets Function–How Kidney Tissue Studies Inform Understanding of Diabetic Kidney Disease
Joint ADA/EASD Symposium–Capillary Glucose Monitoring in 2012
Joint ADA/JDRF Symposium–Antigen-Specific Tolerance in Type 1 Diabetes
Joint ADA/The Lancet Symposium
Kelly West Award Lecture
Late Breaking Abstracts
Macrovascular Disease in Type 1 Diabetes Mellitus
Management of Diabetes on Medical-Surgical Wards
Maternal Diabetes–Exposure, Epigenetics, and Embryopathy (Includes Norbert Freinkel Award Lecture)
Mechanisms of Insulin Resistance in Humans–Inflammation and Lipids
Melanocortin System–Physiology and Regulation
Metabolism In Vivo (Humans)
National Scientific & Health Care Achievement Awards Presentation and Outstanding Scientific Achievement Award Lecture
NDEP Symposium–NDEP Past, Present, and Future–Changing the Way Diabetes Is Treated
New Directions for Diabetes Education in the Inpatient Setting
New Frontiers in Weight Management
New Lessons in Hypertension and Diabetes–An Update on Clinical Trials and Clinical Guidelines
New Players in Energy Metabolism
Novel Agents for Diabetes Management
Novel Brain Mechanisms in Metabolism Regulation
Novel Concepts in the Pathophysiology of Hypoglycemia in Diabetes
Novel Peripheral Targets for Diabesity
Novel Players in Hepatic Lipid Metabolism and Insulin Resistance
Novel Risk Factors for Diabetes
Occurrence of Chronic Complications of Childhood Diabetes in the 21st Century
ORIGIN Trial–Final Results
Pediatric Obesity and Type 2 Diabetes–Phenotypes and Genotypes, Pre- and Post-Diagnosis
Perspectives on Mitochondria Dysfunction in Insulin Resistance
Pleiotropic Actions of Oxidative Stress on Epigenetics
Predictors and Consequences of Diabetic Kidney Disease
Pregnancy and New Metabolic Markers–Impact on Maternal Fetal Health
President, Health Care & Education Address and Outstanding Educator in Diabetes Award Lecture
President, Medicine & Science Address and Banting Lecture
Professional Section Interest Group Discussion on Behavioral Medicine and Psychology–Recruiting and Retaining Minority Participants for Behavioral Diabetes Research–Strategies, Struggles, and Successes
Professional Section Interest Group Discussion on Clinical Endocrinology, Health Care Delivery, and Public Health–Reducing Risk in the Complex Patient with Diabetes–What We Know Works and What We’ve Learned Doesn’t Work
Professional Section Interest Group Discussion on Diabetes in Youth–The Type 1 Diabetes Exchange
Professional Section Interest Group Discussion on Education–Changes, Challenges, and Costs–Looking Ahead to Delivering Diabetes Education
Professional Section Interest Group Discussion on Epidemiology and Statistics Environmental Chemicals and Diabetes Risk, Epidemiology, Pathophysiology, and Exposure Assessment
Professional Section Interest Group Discussion on Exercise–Diabetes and Exercise
Professional Section Interest Group Discussion on Foot Care–Osteomyelitis of the Foot--What Is It and How Do We Treat It ?
Professional Section Interest Group Discussion on Nutritional Science and Metabolism–ATP III Recommends MUFA Intake up to 20% of Calories–Are We Moving in the Right Direction?
Professional Section Interest Group Discussion on Pregnancy and Reproductive Health–Has the White Classification of Diabetes in Pregnancy Outlived its Usefulness?
Protein Acetylation and Other Post Translational Modifications as Metabolic Sensors
Randomized Controlled Trials vs. Translation Research–What Direction for Behavioral Diabetes Research? (Includes Behavioral Medicine and Psychology Distinguished Contributions Award Lecture)
Rare Variants–The Next Genetics Piece in the Diabetes Puzzle
Regenerating the Diabetic Foot
Regulation of Insulin Action through Protein Modification
Sedentary Behavior/Physical Inactivity—Implications for Diabetes
SGLT-Inhibitors
Should We Pay People to Change Their Behavior? Behavioral Economics and Diabetes
Signaling in the Islet
Sleep Disorders and Diabetes–From Epidemiology to Intervention
Social Epidemiology of Diabetes and Associated Conditions
Source of Beta Cells Improving Islet Function
Stimulus-Secretion Coupling in Islet Cells
Supporting Transitions in the Course of Diabetes
Tailoring Diabetes Care for Long-Term Care Settings
Targeting Hypoglycemia
The Basic Science of Exercise–Implications for Diabetes
The Clinical Management of Diabetes
The Effects of Bariatric Surgery on Maternal and Offspring Outcomes
The Holy Grail of Advancing Therapeutics for Diabetic Kidney Disease
The IADPSG/ADA Guidelines for Diagnosing Gestational Diabetes Mellitus and Overt Diabetes–Who’s Adopted Them and Early Feedback
The Role of Pharmacology in Managing Prediabetes
The Tangled Web of Genetics and Environment in Diabetic Kidney Disease
Treatment and Clinical Course of Recent-Onset Type 2 Diabetes in Youth–Data from the TODAY Trial
Type 1 Diabetes–21st Century Update on Incidence, Central Nervous System Effects, and Metabolism
Using the National Prevention Strategy to Turn the Tide on Diabetes
What Are the Ideal Quality Measures for Diabetes Care? (Supported by an unrestricted educational grant from Merck)
What Happens Next after Genome-Wide, Post Genome-Wide Association Studies (GWAS)
Which Technologies Have Impact on Clinical and Behavioral Outcomes in Diabetes?
Why We Need Patient-Reported Outcomes in Clinical Trials
Will PPAR Agonist Therapy Survive?
Women, Diabetes, and Cardiovascular Disease–The Perfect Storm
Clinical Consults: Addressing Dyslipidemia Management Challenges in T2DM Patients—Improving Outcomes Through Guided Patient Solutions (GPS)
El Panorama Siempre Cambiante De La Diabetes: De Los Ensayos Clinicos A La Practica Clinica
Glucose-Lowering Therapy in Patients with Chronic Kidney Disease: Implications for Treatment
Introducing FreeStyle InsuLinx System: An Advancement for Insulin Users
Protecting Vision in Your Diabetic Patients
Real-time Clinical Scenarios: Expert Consults Regarding GLP-1 Receptor Agonist Therapy for Type 2 Diabetes
Reducing CVD Risk in the Patient with High Triglycerides and DM-2: You Be the Judge™
Setting the Stage - Type 1 Diabetes Care. Live Clinician-Patient Conversations on Continuous Insulin Infusion
Waiting for Closed Loop: Tapping the Full Potential of Advanced Diabetes Technology in Today’s Clinical Practice

Registered User

Email Address:

Password:

Forgot your password
Remember me

Refine Your Search

Title:

Speaker:

Session:

Search Text:

Meeting:

Customer Support

FAQ

73rd Scientific Sessions Webcasts will become available in June 2013.